Untreated obesity increases the risk of cardiovascular disease, type 2 diabetes, obstructive sleep apnea, metabolic-associated steatotic liver disease (fatty liver), chronic kidney disease, multiple cancers (endometrial, esophageal, liver, kidney, breast), osteoarthritis, and dementia
Although GLP-1s activity is short lived, it contributes to satiety and blood sugar regulation
Proton pump inhibitors and H2 blockers reduce stomach acid
10.1007/s00726-009-0243-x 115
However, just as there are factors that can influence increased utilization, it is important to consider factors that can reduce the utilization: Utilization Management and Coverage Increase utilization management controls and varying coverage impact on insured access populations resulting in lower adoption rates
Obes Res